FDA approves Rasonque after 13.2-month survival result in metastatic pancreatic cancer
The FDA approved daraxonrasib for advanced pancreatic cancer. UAE clinics and insurers now need a local access plan.
27 Aug 2026 · 3 min read
Topic
drug access
1 articles